REQUEST A DEMO
Total
USD $0.00
Search more companies

Iqvia Rds Czech Republic S.R.O. (Czech Republic)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Custom Computer Programming Services | Management Consulting Services | Advertising Agencies
Full name: Iqvia Rds Czech Republic S.R.O. Profile Updated: February 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

IQVIA RDS Czech Republic S.R.O. operates as a Czech entity within a global life sciences services and technology group, supporting pharmaceutical, biotechnology and medical device customers with research and development and evidence generation capabilities. Business segments and products include clinical research services and operational delivery for clinical trials, including study startup, site management support, monitoring, data management coordination and trial execution services, complemented by advanced analytics and technology-enabled solutions that support evidence generation, real-world data use, outcomes research and commercialization decision-making. The company contributes to multi-country project delivery through specialized teams and standardized processes aligned with global delivery models for regulated clinical and scientific work. Geographic scope and reach is international through participation in global clinical development programs, while maintaining a Czech operating base supporting Central and broader European delivery and global project coordination. Key brands and assets include access to IQVIA data, technology and analytics platforms, a skilled scientific and operational workforce, and global-standard quality and compliance systems required for clinical and regulated research services. Strategic focus and positioning emphasize technology-enabled clinical development, scalable delivery for global trial programs, integration of data and analytics with operational execution, and positioning as a strategic partner that accelerates development timelines and improves decision quality for life sciences customers.

Headquarters
Pernerova 691/42
Prague; The City of Prague; Postal Code: 18600

Contact Details: Purchase the Iqvia Rds Czech Republic S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Iqvia Rds Czech Republic S.R.O. report to view the information.
Registered Capital:
Purchase the Iqvia Rds Czech Republic S.R.O. report to view the information.
Financial Auditors:
Purchase the Iqvia Rds Czech Republic S.R.O. report to view the information.
Incorporation Date:
November 22, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
99.97%
Purchase this report to view the information.
0.03%
Subsidiaries
Clintec International S.R.O.
100%
Company Performance
Financial values in the chart are available after Iqvia Rds Czech Republic S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
9.46%
Total operating revenue
9.47%
Operating Profit/Loss (EBIT)
-14.32%
EBITDA
-12.63%
Net Profit/Loss for the Period
-26.92%
Total Assets
3.85%
Total Equity
-8.27%
Operating Profit Margin (ROS)
-1.19%
Net Profit Margin
-1.51%
Return on Equity (ROE)
-6.25%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?